Skip to main content

Lee Kevin's Form 4 filing

Bicycle Therapeutics PLC (BCYC) · filed Jan 6, 2026

Accession no.
0001776938-26-000002
Filed
Jan 6, 2026
Trade date
Jan 2-5, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $141.2K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lee KevinCIK 0001776938Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 2, 2026Ordinary SharesAGrant or awardAcquired+165,000$0.00$0640,310Direct
Jan 2, 2026Ordinary SharesSSaleDisposed−10,325$6.80−$70,210629,985Direct
Jan 5, 2026Ordinary SharesSSaleDisposed−10,989$6.46−$70,988.94618,996Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 2, 2026Ordinary SharesAGrant or awardAcquired+330,000$0.00$0330,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)